PROGELIFE develops drugs designed for the treatment of rare genetic diseases with premature or accelerated aging.
Automatic translation

Activity area

  • CHILDREN
  • HEALTHTECH
  • PHARMATECH
  • ONCOLOGY
  • SKINTECH
  • BIOTECH

Maturity stage

  • Early bird

Key information

Year of creation

2014

Workforce

< 10

Maturity stage

Early bird

Total fundraising amount

1 715 000 €

Last round table level